Leqembi

For Eisai and Biogen's Leqembi, first FDA-approved Alzheimer's blood test will take time to boost launch: analyst
Fierce Pharma
Mon, 05/19/25 - 10:25 pm
Eisai
Biogen
Alzheimer's disease
Leqembi
diagnostics
Eisai Projects Significant Growth for Alzheimer’s Drug Leqembi
Tip Ranks
Thu, 05/15/25 - 10:31 pm
Eisai
Alzheimer's disease
Leqembi
Leqembi is the First Medicine that Slows Progression of Early Alzheimer’s Disease to be Authorized in the European Union
Stock Titan
Tue, 04/15/25 - 07:49 pm
Leqembi
Alzheimer's disease
Europe
Biogen
Eisai
Five Biggest Drug Face-Offs in Pharma History
BioSpace
Wed, 04/9/25 - 11:38 am
competition
Merck
Bristol Myers Squibb
Keytruda
Opdivo
Pfizer
Bayer
JNJ
Eliquis
Xarelto
Biogen
Eisai
Eli Lilly
Leqembi
Kisunla
AbbVie
Humira
Stelara
AstraZeneca
Calquence
Imbruvica
US vs. EU: When it comes to novel Alzheimer’s drugs, regulators can’t seem to agree
Pharma Voice
Mon, 04/7/25 - 10:06 am
Europe
Biogen
Eisai
Leqembi
Alzheimer's disease
Eisai lays out road map to blockbuster sales projections for Leqembi's 'milestone' 2027 year
Fierce Pharma
Tue, 03/25/25 - 09:43 pm
Eisai
Leqembi
Alzheimer's disease
NICE agrees to look again at Alzheimer's drug Leqembi
Pharmaphorum
Thu, 03/6/25 - 10:59 am
Eisai
Biogen
Leqembi
Alzheimer's disease
UK
NICE
Australia stands firm on 'no' to Alzheimer's drug Leqembi
Pharmaphorum
Mon, 03/3/25 - 10:53 am
Eisai
Biogen
Australia
Alzheimer's disease
Leqembi
Leqembi, after delay, gets back on track toward EU approval
BioPharma Dive
Sun, 03/2/25 - 09:35 pm
Eisai
Biogen
Leqembi
Alzheimer's disease
Europe
Biogen beats estimates on cost cuts and new drugs like Leqembi, but profit outlook falls short
CNBC
Wed, 02/12/25 - 11:08 am
Biogen
earnings
Leqembi
Eisai execs flag Leqembi 'expansion phase' on the horizon as Alzheimer's med grows slowlym
Fierce Pharma
Tue, 02/11/25 - 09:41 pm
Eisai
Leqembi
Alzheimer's disease
Europe to review safety data for Eisai-Biogen Alzheimer's drug
Marketscreener
Fri, 01/31/25 - 11:16 am
Eisai
Biogen
Alzheimer's disease
Leqembi
Europe
Biogen, Eisai Win Nod for Monthly Leqembi Maintenance Amid Stagnant Sales
BioPharma Dive
Mon, 01/27/25 - 11:24 am
Biogen
Eisai
Leqembi
Alzheimer's disease
FDA
Eisai wins over European regulators on Alzheimer’s drug Leqembi
BioPharma Dive
Thu, 11/14/24 - 10:28 pm
Eisai
Biogen
Leqembi
Alzheimer's disease
5 Reasons Biogen’s Shares Have Dropped 36% in 2024
BioSpace
Thu, 11/14/24 - 11:19 am
Biogen
Leqembi
Qalsody
Skyclary
Zurzuvae
Spinraza
Eisai Cuts Fiscal 2024 Guidance for Biogen-Partnered Leqembi as Sales Disappoint Analysts
BioSpace
Sun, 11/10/24 - 09:27 pm
Eisai
Biogen
Leqembi
earnings
Alzheimer's disease
Eisai dials back forecasts for Alzheimer's drug Leqembi
Pharmaphorum
Fri, 11/8/24 - 11:38 am
Eisai
earnings
Leqembi
Alzheimer's disease
Eisai, Biogen eye 2025 approval for Leqembi autoinjector
Pharmaphorum
Fri, 11/1/24 - 10:57 am
Eisai
Biogen
Leqembi
Alzheimer's disease
FDA
Leqembi's vial design could result in hundreds of millions in annual Medicare waste: study
Fierce Pharma
Mon, 10/14/24 - 11:13 pm
Eisai
Biogen
Leqembi
Alzheimer's disease
Eisai, Biogen's Leqembi nabs UK nod, but reimbursement remains elusive
Fierce Pharma
Thu, 08/22/24 - 11:45 am
Eisai
Biogen
Leqembi
UK
Alzheimer's disease

Pages